These emerging therapies , Semaglutide , represent a groundbreaking advancement in managing type 2 diabetes and potentially associated disorders. These drugs are categorized as GLP-1 receptor agonists , meaning they to emulate the body's GLP-1 peptide, boosting metabolic production and lowering hunger . Despite Tirzepatide every operates somewhat s